Cancer incidence
| Site (ICD 9th revision) | Observed | Expected | SIR | 95% CI | |
|---|---|---|---|---|---|
| Lower | Upper | ||||
| All malignant neoplasms (140–208) | 143 | 150.34 | 0.95 | 0.80 | 1.12 |
| Oral cavity and pharynx (140–149) | 5 | 4.45 | 1.12 | 0.36 | 2.62 |
| Oesophagus (150) | 3 | 1.94 | 1.55 | 0.32 | 4.53 |
| Stomach (151) | 5 | 3.77 | 1.33 | 0.43 | 3.10 |
| Colon (153) | 16 | 12.90 | 1.24 | 0.71 | 2.01 |
| Rectum (154) | 6 | 8.63 | 0.70 | 0.25 | 1.51 |
| Liver, specified as primary (1550) | 1 | 1.89 | 0.53 | 0.01 | 2.94 |
| Gall bladder (156) | 1 | 0.54 | 1.86 | 0.05 | 10.31 |
| Pancreas (157) | 2 | 2.48 | 0.81 | 0.10 | 2.91 |
| Larynx (161) | 4 | 1.36 | 2.95 | 0.80 | 7.55 |
| Lung (162) | 26 | 15.29 | 1.70 | 1.11 | 2.49 |
| Bone (170) | 1 | 0.74 | 1.36 | 0.03 | 7.55 |
| Soft tissue (171) | 2 | 2.68 | 0.75 | 0.09 | 2.70 |
| Melanoma (172) | 12 | 21.82 | 0.55 | 0.28 | 0.96 |
| Breast (174–175) | 5 | 9.49 | 0.53 | 0.17 | 1.23 |
| Female genital organs (179–184) | 7 | 4.15 | 1.69 | 0.68 | 3.47 |
| Prostate (185) | 9 | 16.92 | 0.53 | 0.24 | 1.01 |
| Testis (186) | 11 | 5.69 | 1.93 | 0.96 | 3.46 |
| Bladder (188) | 3 | 4.92 | 0.61 | 0.13 | 1.78 |
| Kidney (189) | 3 | 3.96 | 0.76 | 0.16 | 2.22 |
| Brain (191) | 1 | 3.80 | 0.26 | 0.01 | 1.46 |
| Thyroid (193) | 3 | 1.63 | 1.84 | 0.38 | 5.38 |
| Ill defined (195, 199) | 5 | 4.81 | 1.04 | 0.34 | 2.43 |
| Lymphatic and haematopoietic tissue (200–208) | 11 | 13.56 | 0.81 | 0.41 | 1.45 |
| Non-Hodgkin’s lymphoma (200, 202) | 6 | 6.07 | 0.99 | 0.36 | 2.15 |
| Hodgkin’s disease (201) | 1 | 1.31 | 0.76 | 0.02 | 4.24 |
| Leukaemia and aleukaemia (204–208) | 4 | 4.53 | 0.88 | 0.30 | 2.10 |